China Medicine Corporation Appoints PricewaterhouseCoopers As Independent Auditor To Audit Results For Fiscal Years 2006 - 2010
GUANGZHOU, China, Sept. 27, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (Other OTC: CHME.PK) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in the People's Republic of China, tod...
China Medicine Corporation Dismisses Frazer Frost as Auditor
GUANGZHOU, China, Aug. 22, 2011 /PRNewswire-Asia/ -- *China Medicine Corporation* (Other OTC: CHME.PK) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in the People's Republic of China, to...
China Medicine Corporation to Restate Financial Statements for 2006 and 2007
...
China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing
- The Company to Restate Previously Issued Financial Statements - GUANGZHOU, China, March 24, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ...
China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing
GUANGZHOU, China, March 24, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in the People's Republic of Chin...
China Medicine Corporation Adopts New Incentive Compensation Plans
GUANGZHOU, China, March 4, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in the People's Republic of China...
China Medicine Corporation Announces Auditor Will Decline to Stand for Re-Appointment
GUANGZHOU, China, Feb. 23, 2011 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in the People's Republic of China...
China Medicine Corporation Receives Manufacturing License for rADTZ
- Company Reaffirms 2010 Guidance and Provides Full Year 2011 Guidance - GUANGZHOU, China, Feb. 2, 2011 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (the "Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chi...
China Medicine Corporation Announces Additional $2 Million Stock Repurchase Program
- Provides Updates on Ongoing Stock Repurchase Program and rADTZ Application - GUANGZHOU, China, Dec. 30, 2010 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals...
China Medicine Corporation to Participate in the CLSA Emerging Markets Pharma Conference
GUANGZHOU, China, Nov. 25, 2010 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines, and other health products in the People's Repub...
China Medicine Corporation Announces the Appointment of New Chief Financial Officer
GUANGZHOU, China, Nov. 19, 2010 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products in ...
China Medicine Reports Third Quarter 2010 Financial Results
- Schedules Conference Call for November 11, 2010 - - Revises Full Year Guidance - GUANGZHOU, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of West...
China Medicine to Announce Third Quarter 2010 Financial Results on November 10, 2010
-- Company to Hold Conference Call on November 11 at 8:00 am ET -- GUANGZHOU, China, Oct. 23 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chin...
China Medicine Reports Second Quarter 2010 Financial Results
Gross Margin Increases to 35.6% from 23.4% Conference Call Scheduled for August 13, 2010 GUANGZHOU, China, Aug. 13 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of ...
China Medicine to Announce Second Quarter 2010 Financial Results on August 12, 2010
-- Company to Hold Conference Call on August 13th at 8:00 am ET -- GUANGZHOU, China, Aug. 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditio...
China Medicine Announces Stock Repurchase Plan
GUANGZHOU, China, July 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other health products, today announce...
China Medicine Announces Results of Annual Meeting of Stockholders
GUANGZHOU, China, June 3 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other nutraceuticals, today ...
China Medicine Announces First Quarter 2010 Results and Issues Full Year Guidance
- Year-over-year gross margin expansion to 30.7% from 27.5% - Expect 2010 revenue of $72-$76 million and gross margin of 33-38% GUANGZHOU, China, May 13 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), primarily a manuf...
China Medicine Announces Conference Call to Discuss First Quarter 2010 Results
GUANGZHOU, China, May 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) is a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutraceuticals, medical devices, and medical formulations, to...
China Medicine Appoints New CFO, Nominates Three New Directors
GUANGZHOU, China, May 3 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other nutraceuticals, today a...
